- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01956370
Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting
Phase II - Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult Male Circumcision Programs in Zimbabwe (Comparative Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Models show that to have the highest impact on the HIV epidemic, circumcision of up to 80% of men in high prevalence countries, where MC rates are low, needs to be achieved (UNAIDS 2009; Manicaland HIV/STD Prevention Project, 2008; Bollinger, et al, 2009). Hallett and colleagues in 2008 showed that for Zimbabwe specifically, HIV incidence could be reduced between 25% to 35% if about 50% of men are circumcised. All modelings conducted show that MC programs must be part of a comprehensive HIV prevention package as MC alone will not tip the HIV epidemic into a terminal decline.
The PrePex Device offers hope for rapid scale up of adult male circumcision in resource limited settings.
Once the safety and efficacy have been established, it is important to conduct operations research to determine how best to implement both device and surgical circumcisions in the national program. Thus, the Zimbabwe MOHCW is planning a three phase trial in order to determine the safety of the PrePexTM device, its performance and the ease of use in an implementation roll out.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Harare, Zimbabwe
- Znfpc Spilhaus Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages 18 - 30 years
- Uncircumcised
- Wants to be circumcised
- Agrees to be circumcised by any of the study methods,PrePexTM or Surgical as appropriate
- HIV sero-negative
- Able to understand the study procedures and requirements
- Agrees to abstain from sexual intercourse and to keep caution not to directly rub the cut area if masturbating, for 8 weeks post removal (9 weeks total)
- Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 8 weeks post removal (9 weeks total)
- Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
- Subject agrees to anonymous video and photographs of the procedure and follow up visits
- Agrees to stay overnight at the Hospital in order to follow pain measurements in the first 16 hours
Exclusion Criteria:
- Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
- HIV sero-positive
- Subject with the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
- Known bleeding / coagulation abnormality
- Uncontrolled diabetes
- Subject that to the opinion of the investigator is not a good candidate
- Subject does not agree to anonymous video and photographs of the procedure and follow up visits
- Refusal to take HIV test.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: PrePex™ device
Intervention 'PrePex™ device for adult male circumcision
|
The PrePex™ device is designed to enable bloodless male circumcision procedure with no anesthesia and no sutures.
Other Names:
|
|
ACTIVE_COMPARATOR: Surgical
Adult male surgical circumcision
|
The penis will be surgically circumcised according to one of the WHO recommended circumcision methods as described in the Manual for Male Circumcision under Local Anaesthesia Version 2.5C January 2008
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedure time
Time Frame: 9 weeks
|
To compare the total operative time of the PrePex Device circumcision procedure versus the total operative time of surgical circumcision procedure.
|
9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expectations of men regarding the procedure
Time Frame: 9 weeks
|
Expectations of men regarding the procedure using questionnaires
|
9 weeks
|
|
Satisfaction rate of the procedure
Time Frame: 9 weeks
|
Satisfaction with procedure using questionnaires and evaluations
|
9 weeks
|
|
Attitudes towards procedure
Time Frame: 9 weeks
|
Attitudes towards procedure using questionnaires
|
9 weeks
|
|
Sharing information with family and friends
Time Frame: 9 weeks
|
Sharing information with family and friends by evaluating weather subjects would recommend the procedure to others using questionnaires
|
9 weeks
|
|
Perception of norms
Time Frame: 9 weeks
|
Perception of norms using questionnaires
|
9 weeks
|
|
Sexual relations, performance, satisfaction
Time Frame: 9 weeks
|
Sexual relations, performance, satisfaction using questionnaires
|
9 weeks
|
|
Sexual behavior
Time Frame: 9 weeks
|
Sexual behavior using questionnaires.
Inquiring of sexual behavior before and after the circumcision, etc.
|
9 weeks
|
|
Sexual partner's attitudes
Time Frame: 9 weeks
|
Sexual partner's attitudes using questionnaires and investigating the partner's behavior change as a result of her partner's circumcision.
|
9 weeks
|
|
Effect on daily activities
Time Frame: 9 weeks
|
Effect on daily activities using questionnaires.
Inquiring and finding out if the MC procedure caused any missing of working days.
|
9 weeks
|
|
Costs
Time Frame: 9 weeks
|
Evaluating the cost of PrePex circumcision procedure when taking into account the following parameters: i. PrePex Procedure time and the resulting cost of provider's time ii. Cost of staff time for follow-up visits iii. Cost of equipment and supplies needed for the circumcision procedure |
9 weeks
|
|
Cost-effectiveness
Time Frame: 9 weeks
|
Cost-effectiveness
|
9 weeks
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Hohlfeld A, Ebrahim S, Shaik MZ, Kredo T. Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions. Cochrane Database Syst Rev. 2021 Mar 31;3(3):CD012250. doi: 10.1002/14651858.CD012250.pub2.
- Tshimanga M, Mangwiro T, Mugurungi O, Xaba S, Murwira M, Kasprzyk D, Montano DE, Nyamukapa D, Tambashe B, Chatikobo P, Gundidza P, Gwinji G. A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex Device to Forceps Guided Surgical Circumcision in Zimbabwe. PLoS One. 2016 May 26;11(5):e0156220. doi: 10.1371/journal.pone.0156220. eCollection 2016.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MRCZ/A/1628 Comparative study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on PrePex™ device for adult male circumcision
-
Ministry of Health, RwandaCompleted
-
Ministry of Health, RwandaMinistry of Defence, RwandaCompletedHIV Infections | HIV Prevention | Male CircumcisionRwanda
-
FHI 360University of Illinois at Chicago; Bill and Melinda Gates Foundation; Nyanza... and other collaboratorsCompleted
-
University of WashingtonCenters for Disease Control and Prevention; University of Zimbabwe; Ministry... and other collaboratorsCompleted
-
Weill Medical College of Cornell UniversityEngenderHealthCompletedHIV Infections | HIV Prevention | Male CircumcisionKenya
-
National Institute of Allergy and Infectious Diseases...Fogarty International Center of the National Institute of HealthCompletedHIV Infections | Syphilis | Genital Diseases, Male | Herpesvirus 2, HumanUganda
-
EngenderHealthWeill Medical College of Cornell University; Kenya Ministry of Health; Kenya...CompletedHuman Immunodeficiency VirusKenya
-
Ministry of Health, RwandaCompletedMedical Device ComplicationRwanda
-
Ministry of Health, RwandaCompletedHIV Prevention | Male Circumcision | Screen Failure Subjects | Narrow ForeskinRwanda
-
Ministry of Health, RwandaCompletedHIV Prevention | Male CircumcisionRwanda